AmL, MDS, MPN
21 days
Next Generation Sequencing
Gene list (73): ABL1, ANKRD26, ASXL1, ASXL2, ATRX, BCOR, BCORL1, BRAF, CALR, CBL, CDKN2A, CEBPA, CSF3R, CUX1, DDX41, DNMT3A, ELANE, ETNK1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, IKZF1, IL7R, JAK1, JAK2, JAK3, KDM6A, KIT, KMT2A, KRAS, MPL, MYD88, NF1, NOTCH1, NPM1, NRAS, PDGFRA, PHF6, PIGA, PPM1D, PRPF8, PTEN, PTPN11, RAD21, RB1, RUNX1, SETBP1, SETD2, SF1, SF3B1, SH2B3, SAMD9, SAMD9L, SMC1A, SMC3, SRSF2, SUZ12, STAG2, STAT3, STAT5B, TERT, TET2, TP53, U2AF1, WT1, ZRSR2
Accredited NRL Laboratory
Once a week
Genetic profiling of myeloid neoplasms; inform diagnosis and treatment.
Peripheral blood,Bone Marrow Aspirate, Bone Marrow Aspirate Smears (Unstained Slides), FFPE of Bone Marrow Clott
5-5 mL1.5-3 mL5 USS with minimum 3,000 cells10 USS with 1H&E
Lavender-top (EDTA) tube, Slide Holder
No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.
This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.
| Temperature | Period |
|---|---|
| Room temperature | 3 years for USS and FFPE |
| Refrigerated | 7 days Blood and Bone marrow |